Page last updated: 2024-09-04

chs 828 and cb 30865

chs 828 has been researched along with cb 30865 in 2 studies

Compound Research Comparison

Studies
(chs 828)
Trials
(chs 828)
Recent Studies (post-2010)
(chs 828)
Studies
(cb 30865)
Trials
(cb 30865)
Recent Studies (post-2010) (cb 30865)
21017705

Protein Interaction Comparison

ProteinTaxonomychs 828 (IC50)cb 30865 (IC50)
Thymidylate synthaseHomo sapiens (human)0.156
Thymidylate synthaseMus musculus (house mouse)0.156

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fakhfouri, G; Galli, U; Genazzani, AA; Massarotti, A; Rahimian, R; Travelli, C; Tron, GC1
Björkling, F; Christensen, MK; Erichsen, KD; Fristrup, P; Garten, A; Jensen, PB; Kalvinsh, I; Kiess, W; Loza, E; Nielsen, SJ; Olesen, UH; Sehested, M; Thougaard, A; Tjørnelund, J1

Reviews

1 review(s) available for chs 828 and cb 30865

ArticleYear
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.
    Journal of medicinal chemistry, 2013, Aug-22, Volume: 56, Issue:16

    Topics: Crystallography, X-Ray; Enzyme Inhibitors; Humans; Models, Molecular; Nicotinamide Phosphoribosyltransferase; Structure-Activity Relationship

2013

Other Studies

1 other study(ies) available for chs 828 and cb 30865

ArticleYear
Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.
    Journal of medicinal chemistry, 2013, Nov-27, Volume: 56, Issue:22

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Design; Enzyme Inhibitors; Guanidines; Humans; Hydrogen Bonding; Hydroxamic Acids; Inhibitory Concentration 50; Mice; Molecular Docking Simulation; Nicotinamide Phosphoribosyltransferase; Protein Conformation; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2013